CLINICAL_TRIALS
trial_result
· 2019-07-26
Clinical Trial Update: Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC
Summary
Observational study assessing efficacy and quality of life effects of targeted treatments after TKIs in renal cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2019-07-26